Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes.
Giotta F, Acito L, Candeloro G, Del Medico P, Gadaleta-Caldarola G, Giordano G, Gueli R, Lugini A, Magri V, Mandarà M, Masci G, Pisconti S, Pistelli M, Rizzi A, Salesi N, Schirone A, Scognamiglio G, Tedeschi M, Zucchinelli P. Giotta F, et al. Among authors: masci g. Oncologist. 2016 Nov;21(11):1298-1305. doi: 10.1634/theoncologist.2016-0022. Epub 2016 Oct 14. Oncologist. 2016. PMID: 27742906 Free PMC article.
Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.
Masci G, Caruso M, Caruso F, Salvini P, Carnaghi C, Giordano L, Miserocchi V, Losurdo A, Zuradelli M, Torrisi R, Di Tommaso L, Tinterri C, Testori A, Garcia-Etienne CA, Gatzemeier W, Santoro A. Masci G, et al. Oncologist. 2015 Jun;20(6):586-92. doi: 10.1634/theoncologist.2014-0243. Epub 2015 May 6. Oncologist. 2015. PMID: 25948676 Free PMC article.
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M, Alongi F, Fogliata A, Pentimalli S, Navarria P, Lobefalo F, Garcia-Etienne C, Clivio A, Cozzi L, Mancosu P, Nicolini G, Vanetti E, Eboli M, Rossetti C, Rubino A, Sagona A, Arcangeli S, Gatzemeier W, Masci G, Torrisi R, Testori A, Alloisio M, Santoro A, Tinterri C. Scorsetti M, et al. Among authors: masci g. Radiat Oncol. 2012 Aug 28;7:145. doi: 10.1186/1748-717X-7-145. Radiat Oncol. 2012. PMID: 22929062 Free PMC article.
Outcome Evaluation of HER2 Breast Cancer Patients with Limited Brain Metastasis.
Pessina F, Navarria P, Cozzi L, Franceschini D, Tomatis S, Clerici E, Ascolese AM, DE Rose F, Bello L, Masci G, Santoro A, Scorsetti M. Pessina F, et al. Among authors: masci g. Anticancer Res. 2017 Dec;37(12):7057-7062. doi: 10.21873/anticanres.12177. Anticancer Res. 2017. PMID: 29187495
Never too old to fight breast cancer: A case report.
Zuradelli M, Masci G, Ferraro E, Losurdo A, De Sanctis R, Torrisi R, Santoro A. Zuradelli M, et al. Among authors: masci g. Medicine (Baltimore). 2018 Mar;97(9):e9981. doi: 10.1097/MD.0000000000009981. Medicine (Baltimore). 2018. PMID: 29489698 Free PMC article.
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients.
De Sanctis R, Agostinetto E, Masci G, Ferraro E, Losurdo A, Viganò A, Antunovic L, Zuradelli M, Torrisi RMC, Santoro A. De Sanctis R, et al. Among authors: masci g. Oncology. 2018;94 Suppl 1(Suppl 1):19-28. doi: 10.1159/000489065. Epub 2018 Jul 23. Oncology. 2018. PMID: 30036884 Free PMC article.
Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
Agostinetto E, Giordano L, Torrisi R, De Sanctis R, Masci G, Losurdo A, Zuradelli M, Tinterri C, Gatzemeier W, Testori A, Alloisio M, De Rose F, Fernandes B, Santoro A. Agostinetto E, et al. Among authors: masci g. Clin Breast Cancer. 2020 Aug;20(4):e481-e489. doi: 10.1016/j.clbc.2020.02.011. Epub 2020 Mar 6. Clin Breast Cancer. 2020. PMID: 32279915
130 results